Age-related macular degeneration and nutritional supplementation: A review of randomised controlled trials

Ophthalmic and Physiological Optics

Volumn 23, Issue 5, 2003, Pages 383-399

  Bartlett, Hannah ^a   Eperjesi, Frank ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Age related macular degeneration; Antioxidants; Carotenoids; Lutein; Randomised controlled trials

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BUPHENINE; GLUCONATE ZINC; VISALINE; XANTHOPHYLL; ZEAXANTHIN; ZINC OXIDE; ZINC SULFATE; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID; DRUG DERIVATIVE; VITAMIN; ZINC;

CLINICAL TRIAL; DIET THERAPY; DISEASE COURSE; DOSE RESPONSE; DRUG BIOAVAILABILITY; HUMAN; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; REVIEW; RISK FACTOR; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG COMBINATION; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ALPHA-TOCOPHEROL; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CAROTENOIDS; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; HUMANS; LUTEIN; MACULAR DEGENERATION; NYLIDRIN; RANDOMIZED CONTROLLED TRIALS; VITAMIN E; VITAMINS; ZINC;

EID: 0242273158     PISSN: 02755408     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1475-1313.2003.00130.x     Document Type: Review

References (146)

1. Abramson, D. and Abramson, H. (2002) High-dose supplements for age-related macular degneration: did you leave out centrum? Arch. Ophthalmol. 120, 1602.
2. Algvere, P. V. and Seregard, S. (2002) Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol. Scand. 80, 136-143.
3. Alvarez, R., Liou, G. and Fong, S. (1987) Levels of alpha- and gamma-tocopherol in human eyes: evaluation of the possible role of IRBP in intraocular alpha-tocopherol transport. Am. J. Clin. Nutr. 46, 481-487.
4. Armstrong, R., Slade, S. and Eperjesi, F. (2000) An introduction to analysis variance (ANOVA) with special reference to data from clinical experiments in optometry. Ophthal. Physiol. Opt. 20, 235-241.
5. Beardsley, T. (1991) The A Team. Vitamin A and its cousins are potent regulators of cells. Sci. Am. 16-19.
6. Beatty, S., Boulton, M., Henson, D., Koh, H. H. and Murray, I. J. (1999) Macular pigment and age related macular degeneration. Br. J. Ophthalmol. 83, 867-877.
7. Beatty, S., Koh, H., Carden, D. and Murray, I. (2000) Macular pigment optical density measurement: a novel compact instrument. Ophthal. Physiol. Opt. 20, 105-111.
8. Beatty, S., Murray, I. J., Henson, D. B., Carden, D., Koh, H. and Boulton, M. E. (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest. Ophthalmol. Vis. Sci. 42, 439-446.
9. Berendschot, T. T., Goldbohm, R. A., Klopping, W. A., van de Kraats, J., van Norel, J. and van Norren, D. (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest. Ophthalmol. Vis. Sci. 41, 3322-3326.
10. Berger, A. (2002) Science commentary: what does zinc do? Br. Med. J. 325, 1063-1063.
11. Bernstein, P. S. (2002) New insights into the role of the macular carotenoids in age-related macular degeneration. Resonance Raman studies. Pure Appl. Chem. 74, 1419-1425.
12. Bielski, B. (1982) Chemistry of ascorbic acid radicals. Ascorbic acid: chemistry, metabolism, and uses. Adv. Chem. Ser. 200, 81-100.
13. Bird, A. (1996) Age-related macular disease. Br. J. Ophthalmol. 80, 2-3.
14. Bird, A. and Marshall, J. (1986) Retinal pigment epithelium detachments in the elderly. Trans. Ophthalmol. Soc. UK 105, 674-682.
15. Bird, A. E. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., Dejong, P., Klaver, C. C. W., Klein, B. E. K., Klein, R., Mitchell, P., Sarks, J. P., Sarks, S. H., Sourbane, G., Taylor, H. R. and Vingerling, J. R. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv. Ophthalmol. 39, 367-374.
16. Bischoff, P. and Flower, R. (1983) High blood pressure in choroidal arteries as a possible pathogenetic machanism in senile macular degeneration. Am. J. Ophthalmol. 96, 398-399.
17. Bodannes, R. and Chan, P. (1979) Ascorbic acid as a scavenger of singlet oxygen. FEBBS Lett. 105, 195-196.
18. Bone, R., Landrum, J. and Tarsis, S. (1985) Preliminary identification of the human macular pigment. Vision Res. 25, 1531-1535.
19. Bone, R., Landrum, J. T. and Fernandez, L. (1988) Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest. Ophthalmol. Vis. Sci. 29, 843-849.
20. Bone, R. A., Landrum, J. T., Mayne, S., Gomez, C., Tibor, S. and Twaroska, E. (2001) Macular pigment in donor eyes with and without AMD: A case-control study. Invest. Ophthalmol. Vis. Sci. 42, 235-240.
21. Bressler, N. M. and Bressler, S. B. (1995) Preventative ophthalmology - age-related macular degeneration. Ophthalmology 102, 1206-1211.
22. Burton, G., Foster, D., Perly, B., Slater, T., Smith, I. and Ingold, K. (1985) Biological antioxidants. Philos. Trans. R. Soc. Lond. B Biol. Sci. 311, 565-578.
23. Burton, G. and Ingold, K. (1984a) Autoxidation of biological molecules: 1: The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Assoc. 103, 6472-6477.
24. Burton, G. and Ingold, K. (1984b) Beta-carotene: an unusual type of lipid antioxidant. Science 224, 569-573.
25. Chuang, E. and Bird, A. (1988) The pathogenesis of tears of the retinal pigment epithelium. Am. J. Ophthalmol. 105, 185-190.
26. Clarke, M. P., Pearson, J. C. G., Vernon, S. A. and Matthews, J. C. (1990) Influence of pupil size on measurements made with the Lens Opacity Meter 701. Br. J. Ophthalmol. 74, 526-527.
27. Costagliola, C., Iuliano, G., Marino, E., Paolercio, F., Trapanese, A. and Apponibattini, G. (1990) Quantification and measurement of human lens opacities using the Lens Opacity Meter. Ophthalmologica 201, 45-48.
28. Curcio, C. and Millican, C. (1999) Basal linear deposits and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 117, 329-339.
29. Delcourt, C., Cristol, J. P., Tessier, F., Leger, C. L., Descomps, B. and Papoz, L. (1999) Age-related macular degeneration and antioxidant status in the POLA study. Arch. Ophthalmol. 117, 1384-1390.
30. Department of Health (1992) The Nutrition of Elderly People Report on Health and Social Subjects. HMSO, UK.
31. Dilley, R. and McConnell, D. (1970) Alpha-tocopherol in the retinal outer segment of bovine eyes. J. Mem. Biol. 2, 317-323.
32. Drevon, C. (1991) Absorption, transport and metabolism of vitamin E. Free Radic. Res. Commun. 14, 229-246.
33. Dunlap, W., James, G. and Hume, D. (1974) Anaemia and neutropenia caused by copper deficiency. Ann. Intern. Med. 80, 470-476.
34. Eckhert, C. (1979) A comparative study of the concentrations of Ca, Fe, Zn and Mn in ocular tissues. Fed. Proc. 38, 872.
35. EDCCS Group (1992) Risk Factors for age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch. Ophthalmol. 110, 1701-1708.
36. EDCCS Group (1993) Antioxidant status and neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch. Ophthalmol. 111, 104-109.
37. Evans, J. and Henshaw, K. (2002) Antioxidant vitamin and mineral supplementation for preventing age-related macular degeneration (Cochrane Review). The Cochrane Library. Update Software, Oxford.
38. Evans, J. and Wormald, R. (1996) Is the incidence of registrable age-related macular degeneration increasing? Br. J. Ophthalmol. 80, 9-14.
39. Farber, D., Flannery, J., Lolley, R. and Bok, D. (1985) Distribution patterns of photoreceptors, protein, and cyclic nucleotides in the human retina. Invest. Ophthalmol. Vis. Sci. 26, 1558-1568.
40. Feeney-Burns, L. and Ellersieck, M. (1985) Age-related changes in the ultrastructure of Bruch's membrane. Am. J. Ophthalmol. 100, 686-697.
41. Fischer, P., Giroux, A. and L'Abbe, M. (1983) Effects of zinc on mucosal copper binding and on the kinetics of copper absorption. J. Nutr. 113, 462-469.
42. Flanagan, P., Haist, J. and Valberg, L. (1983) Zinc absorption, intraluminal zinc and intestinal metallothionein levels in zinc-deficient and zinc-replete rodents. J. Nutr. 113, 962-972.
43. Friedman, E., Krupsky, S., Lane, A., Oak, S., Friedman, E., Egan, K. and Gragoudas, E. (1995) Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102, 640-646.
44. Fukuzawa, K. and Gebicki, J. (1983) Oxidation of alpha-tocopherol in micelles and liposomes by the hydroxyl, perhydroxyl, and superoxide free radicals. Arch. Biochem. Biophys. 226, 242-251.
45. Galin, M., Nano, H. and Hall, T. (1962) Ocular zinc concentration. Invest. Ophthalmol. Vis. Sci. 1, 142-148.
46. Gey, K., Stahalin, H. and Eichholzer, M. (1993) Poor plasma status of carotene and vitamin C is associated with higher mortality from ischaemic heart disease and stroke: Basel Prospective Study. Clin. Investig. 71(1), 3-6.
47. Gray, J. A. M. (1997) Evidence-based Healthcare. How to Make Health Body and Mangement Decisions. Churchill-Livingstone, UK.
48. Halliwell, B. and Gutteridge, J. (1999) Free Radicals in Biology and Medicine. Oxford University Press, London.
49. Ham, W. (1983) Ocular hazards of light sources: review of current knowledge. J. Occup. Med. 25, 101-103.
50. Ham, W., Mueller, H. and Ruffolo, J. (1984) Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr. Eye Res. 3, 165-174.
51. Ham, W. and Mueller, W. (1989) The photopathology and nature of the blue-light and near-UV retinal lesion produced by lasers and other optical sources. In: Laser Applications in Medicine and Biology (eds M. Wolbarsht) Plenum Press, New York, pp. 191-246.
52. Hammond, B. J., Woolen, B. and Snodderly, D. (1997) Individual variations in the spatial profile of human macular pigment. J. Am. Optom. Assoc. 14, 1187-1196.
53. Hammond, B. R., Ciulla, T. A. and Snodderly, D. M. (2002) Macular pigment density is reduced in obese subjects. Invest. Ophthalmol. Vis. Sci. 43, 47-50.
54. Hammond, B. and Caruso-Avery, M. (2000) Macular pigment optical density in a Southwestern sample. Invest. Ophthalmol. Vis. Sci. 41, 1492-1497.
55. Handelman, G., Machlin, L. and Fitch, K. (1985) Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J. Nutr. 115, 807-813.
56. Handelman, G., Dratz, E. and Reay, C. (1988) Carotenoids in the human macula and the whole retina. Invest. Ophthalmol. Vis. Sci. 29, 850-855.
57. Hawkins, B. S., Bird, A., Klein, R. and West, S. K. (1999) Epidemiology of age-related macular degeneration. Mol. Vis. 5, U7-U10.
58. Hemila, H., Roberts, P. and Wikstrom, M. (1985) Activated polymorphonuclear leucocytes consume vitamin C. FEBS Lett. 178, 25-30.
59. Huber, A. and Gershoff, S. (1975) Effects of zinc deficiency on the oxidation of etinol and ethanol in rats. Nutrition 105, 1486-1490.
60. Hulley, S., Cummings, S., Browner, W., Grady, D., Hearst, N. and Newman, T. (2001) Designing Clinical Research. Lippincott Williams & Wilkins, Philadelphia.
61. Hunt, D. F., Organisciak, D. T. and Wu, R. C. (1984) Alpha-tocopherol in the developing rat retina: a high pressure liquid Chromatographic analysis. Curr. Eye Res. 3, 1281-1288.
62. Huwiler-Muntener, K., Juni, P., Junker, C., Egger, M. (2002) Quality of reporting randomized trials as a measure of methodologic quality. J. Am. Med. Soc. 287, 2801-2804.
63. Hyman, L. G., Lilienfeld, A. M., Ferris, F. L. and Fine, S. L. (1983) Senile macular degeneration - a case-control study. Am. J. Epidemiol. 118, 213-227.
64. Ishibashi, T., Sorgente, N., Patterson, R. and Ryan, S. (1986) Pathogenesis of drusen in the primate. Invest. Ophthalmol. Vis. Sci. 27, 184-193.
65. Jacques, P. F. (1992a) Relationship of vitamin C status to cholesterol and blood pressure. Ann. N. Y. Acad. Sci. 669, 205-214.
66. Jacques, P. F. (1992b) Effects of vitamin C on high density lipoprotein cholesterol and blood pressure. Am. J. Coll. Nut. 11, 139-144.
67. Kaiser, H. J., Flammer, J., Stumpfig, D. and Hendrickson, P. (1995) Visaline in the treatment of age-related macular degeneration - a pilot-study. Ophthalmologica 209, 302-305.
68. Kaplan, J., Gerber, S. and Larget-Piet, D. (1993) A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat. Genet. 5, 308-311.
69. Karcioglu, Z. (1982) Zinc and the eye. Surv. Ophthalmol. 27, 114-122.
70. Khachik, F. and Beecher, G. (1987) Application of a c-45-b-carotene as an internal standard for the quantification of carotenoids in yellow/orange vegetables by liquid chromatography. J. Agricult. Food Chem. 35, 732-738.
71. Khachik, F. and Beecher, G. (1988) Separation and identification of carotenoids and carotenol fatty acid esters in some squash products by liquid chromatography. 1. Quantification of carotenoids and related esters by HPLC. J. Agricult. Food Chem. 36, 929-937.
72. Khachik, F., Beecher, G. and Lusby, W. (1989) Separation, identification, and quantification of the major carotenoids in extracts of apricots, peaches, cantaloupe and pink grapefruit by liquid chromoatography. J. Agricult. Food Chem. 37, 1465-1473.
73. Khachik, F., Beecher, G. and Goli, M. (1991) Separation, identification, and quantification of carotenoids in fruits, vegetables and human plasma by higg performance liquid chromatography. Pure Appl. Chem. 63, 71-80.
74. Khachik, F., Beecher, G. and Goli, M. (1992) Separation and quantification of carotenoids in foods. In: Methods in enzymology (eds L. Packer), Academic Press, San Diego, pp. 347-359.
75. Khachik, F., Bernstein, P. S. and Garland, D. L. (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest. Ophthalmol. Vis. Sci. 38, 1802-1811.
76. Klein, R., Klein, B. E. K. and Linton, K. L. P. (1992) Prevalence of age-related maculopathy - the Beaver Dam Eye Study. Ophthalmology 99, 933-943.
77. Klein, R., Klein, B. and Franke, T. (1993) The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 100, 406-414.
78. Klein, R., Wang, Q. and Klein, B. (1995) The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest. Ophthalmol. Vis. Sci. 36, 182-191.
79. Klein, R. (1999) Epidemiology. In: Age-related Macular Degeneration (eds J.W. Berger, S.L. Fine, M.G. Maguire), Mosby, London, pp. 31-55.
80. Klevay, L. M. (2000) Cardiovascular disease from copper deficiency - a history. J. Nut. 130, 489S-492S.
81. Kornzweig, A. (1977) Changes in the choriocapillaris associated with senile macular degeneration. Ann. Ophthalmol. 9, 753-764.
82. Landrum, J. T. and Bone, R. A. (2001) Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys. 385, 28-40.
83. Lazarides, L. (1997) The Nutritional Health Bible. Harper Collins, London.
84. Leo, M. A. and Lieber, C. S. (1997) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 89, 1722-1723.
85. Linder, M., Chang, T. S., Scott, I. U., Hay, D., Chambers, K., Sibley, L. M. and Weis, E. (1999) Validity of the Visual Function Index (VF-14) in patients with retinal disease. Arch. Ophthalmol. 117, 1611-1616.
86. Machlin, L. (1980) Vitamin E: A Comprehensive Treatise. Dekker, New York.
87. Machlin, L. and Bendich, A. (1987) Free radical tissue damage: protective role of antioxidant nutrients. Faseb. J. 1, 441-445.
88. Mangels, A., Holden, J. and Beecher, G. (1993) Carotenoid content of fruits and vegetables: an evaluation of analytic data. J. Am. Diet. Assoc. 93, 284-296.
89. Manson, J., Stampfer, M. and Willett, W. (1991) A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 84, 546 (abstract).
90. Martin, H., Ruck, C., Schmidt, M., Sell, S., Beutner, S., Mayer, B. and Walsh, R. (1999) Chemistry of carotenoid oxidation and free radical reactions. Pure Appl. Chem. 71, 2253-2262.
91. Mathews-Roth, M. (1986) Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Biochemie 68, 875-884.
92. McCay, P. (1985) Vitamin E: interactions with free radicals and ascorbate. Ann. Rev. Nut. 5, 323-340.
93. McClain, C., Kararskis, E. and Allen, J. (1985) Functional consequences of zinc deficiency. Prog. Food Nutr. Sci. 9, 185-226.
94. Mellerio, J. (2001) Characteristics of macular pigment may be used to measure pigment density psychophysically. Report of the Special Interest Symposium: Xanthophyll Carotenoids and the Macular Pigment Lutein, Roche Vitamins, 5-6.
95. Moore, D., Hussain, A. and Marshall, J. (1995) Age-related variation in the hydraulic conducitivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 36, 1290-1297.
96. Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C. and Miller, E. (1988) Oral zinc in macular degeneration. Arch. Ophthalmol. 106, 192-198.
97. Nishikimi, M. (1975) Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem. Biophys. Res. Commun. 63, 463-468.
98. Oison, J. A. (1984) Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J. Natl. Cancer Inst. 73, 1439-1444.
99. Ong, A. and Tee, E. (1992) Natural sources of carotenoids from plants and oils. In: Methods in Enzymology (ed. L. Packer) Academic Press, London, 142-167.
100. Osilesi, O., Trout, D. and Ogunwole, J. (1991) Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nut. Res. 11, 402-412.
101. Ozawa, T., Hanaki, A. and Matsuo, M. (1983) Reactions of Superoxide ion with tocopherol and model compounds: correlation between the physiological activities of tocopherols and the concentration of chromanoxyl-radicals. Biochem. Int. 6, 685-692.
102. Pauleikhoff, D., Harper, C., Marshall, J. and Bird, A. (1990) Ageing changes in Bruch's membrane. A histochemical and morphological study. Ophthalmology 97, 171-178.
103. Pippenger, C., Zianzhong, M. and Rothner, D. (1991) Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions. In: Idiosyncratic Reactions to Valproate: Clinical Risk Patterns and Mechanisms of Toxicity (eds J. Penry) Raven Press, New York, pp. 75-88.
104. Potts, A. (1966) An hypothesis on macular disease. Trans. Am. Acad. Ophthalmol. Otolaryngol. 70, 1058-1062.
105. Richer, S., Stiles, W., Statkute, L., Pei, K., Frankowski, J., Nyland, J., Pulido, J. and Rudy, D. (2002) The lutein antioxidant supplementation trial (E-Abstract 2542). Invest. Ophthalmol. Vis. Sci. 43.
106. Ridgman, W. (1975) Experimentation in Biology. Blackie, London.
107. Schalch, W. (1992) Carotenoids in the retina - a review of their possible role in preventing or limiting light damage caused by light and oxygen. In: Free Radicals and Aging (eds B. Chance) Birkhauser, Verlag, Basel, pp. 280-298.
108. Schalch, W. (2001) Importance of the carotenoids lutein and zeaxanthin for the human eye. Part 1. Chim. Oggi-Chem. Today 19, 12-15.
109. Seddon, J. M. (1999) Nutrition and age-related eye disease (Review). Vitamin Nutrition Information Service Backgrounder 2, 1-10.
110. Seddon, J. M., Smith and Smith (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276, 1141-1146.
111. Sheraidah, G., Syeinmetz, R., Maguire, J., Pauleikhoff, D., Marshall, J. and Bird, A. (1993) Corelation between lipids extracted from Bruch's membrane with age. Ophthalmology 100, 47-51.
112. Siegel, E., Craig, G. and Crystal, M. (1961) Distribution of Zn in the prostate and other organs of man. Br. J. Cancer 15, 647-664.
113. Sies, H. (1991) Oxidative stress: from basic research to clinical application. Am. J. Med. 91 (Suppl.), 31-37.
114. Sigel, H. (1983) Metal Ions in Biological Systems. In: Zinc and Its Role in Biology and Nutrition. Dekker, New York.
115. Silvestri, G. (1997) Age-related macular degeneration: genetics and implications for detection and treatment. Mol. Med. Today 3, 84-91.
116. Smith, W. and Mitchell, P. (1996) Alcohol intake and age-related maculopathy. Am. J. Ophthalmol. 122, 743-745.
117. Smith, W. and Mitchell, P. (1998) Family history and age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol. 26, 203-206.
118. Snodderly, D. M., Auran, J. and Delori, F. (1984) The macular pigment II. Spatial distribution in primate retinas. Invest. Ophthalmol. Vis. Sci. 25, 674-685.
119. Snodderly, D. M., Handelman, G. J. and Adler, A. J. (1991) Distribution of individual macular pigment carotenoids in central retinal of macaque and squirrel monkeys. Invest. Ophthalmol. Vis. Sci. 32, 268-279.
120. Solomons, M. (1979) On the assessment of zinc and copper nutriture in man. Am. J. Clin. Nut. 32, 856-871.
121. Solomons, N. and Russell, R. (1980) The interaction of vitamin A and zinc: implications for human nutrition. Am. J. Clin. Nut. 33, 2031-2040.
122. Sommerburg, O., Keunen, J. E., Bird, A. C. and van Kuijk, F. J. (1998) Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br. J. Ophthalmol. 82, 907-910.
123. Stone, E., Nichols, B. and Streb, L. (1992) Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11 q13. Nat. Genet. 1, 246-250.
124. Stone, E., Nichols, B., Kimura, A. and Weingeist, T. (1994) Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch. Ophthalmol. 112, 765-772.
125. Stur, M., Tittl, M., Reitner, A. and Meisinger, V. (1996) Oral zinc and the second eye in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 37, 1225-1235.
126. Swanson, A. and Truesdale, A. (1971) Elemental analysis of normal and caractous human lens tissue. Biochem. Biophys. Res. Commun. 45, 1488-1496.
127. Tamakoshi, A., Yuzawa, M., Matsui, M., Uyama, M., Fujiwara, N. K. and Ohno, Y. (1997) Smoking and neovascular form of age-related macular degeneration in late middle aged males: findings from a case-control study in Japan. Br. J. Ophthalmol. 81, 901-904.
128. Taylor, H. R., Tikellis, G., Robman, L. D., McCarty, C. A. and McNeil, J. J. (2002) Vitamin E supplementation and macular degeneration: randomised controlled trial. Br. Med. J. 325, 11.
129. Teikari, J. M., Laatikainen, L., Virtamo, J., Haukka, J., Rautalahti, M., Liesto, K., Albanes, D., Taylor, P. and Heinonen, O. P. (1998) Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol. Scand. 76, 224-229.
130. The AREDS Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No 8. Arch. Ophthalmol. 119, 1417-1436.
131. The ATBC Cancer Prevention Study Group (1994) The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Eng. J. Med. 330, 1029-1035.
132. Turnland, J., Costa, F. and Fargen, S. (1981) Zinc, copper and iron balance in elderly men. Am. J. Clin. Nut. 34, 2641-2647.
133. Ujiie, M. (1979) Studies on metabolism of trace metals in aqueous humour, ocular tissues and other organ tissues of albino rabbit. Acta Soc. Ophthal. 83, 2149-2157.
134. Urbach, C., Hickman, K. and Harris, P. (1951) Effect of individual vitamins A, C, E and carotene administered at high levels and their concentration in the blood. Exp. Med. Surg. 10, 7-20.
135. Van der Hagen, A., Yolton, D., Kaminski, M. and Yolton, R. (1993) Free radicals and antioxidant supplementation: a review of their roles in age related macular degeneration. J. Am. Optom. Assoc. 64, 871-878.
136. Verhoeff, F. and Grossman, H. (1937) Pathogenesis of disciform degeneration of the macula. Arch. Ophthalmol. 18, 561-585.
137. Vinding, T. (1995) Age-related macular degeneration. Acta Ophthalmol. Scand. 217, 1-32.
138. Vingerling, J. R., Hofman, A., Grobbee, D. E. and deJong, P. (1996) Age-related macular degeneration and smoking-The Rotterdam study. Arch. Ophthalmol. 114, 1193-1196.
139. Vitale, S., West, S. and Hallfrisch, J. (1993) Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 43, 195-203.
140. Wagner, P. (1985) Zinc nutriture in the elderly. Geriatrics 40, 111-125.
141. Wagner, P., Jernigan, J. and Bailey, L. (1983) Zinc nutriture and cell-mediated immunity in the aged. Int. J. Vitam. Nutr. Res. 53, 94-101.
142. Wald, G. (1945) Human vision and the spectrum. Science 101, 653-658.
143. Werner, J., Donnelly, S. and Kliegl, R. (1987) Aging and human macular pigment density: appended with translations from the work of Max Schultze and Ewald Hering. Vision Res. 27, 257-268.
144. West, S., Vitale, S., Hallfrisch, J., Munoz, B., Muller, D., Bressler, S. and Bressler, N. M. (1994) Are antioxidants or supplements protective for age-related macular degeneration. Arch. Ophthalmol. 112, 222-227.
145. Williams, H., Fenna, D. and MacBeth, R. (1971) Alphatocopherol in the treatment of intermittent claudication. Surg. Gynecol. Obstet. 132, 662-666.
146. Zhang, K., Bither, P. and Park, R. (1994) A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34. Arch. Ophthalmol. 112, 759-764.